Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward F Patz

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
JAMA Internal Medicine|December 11, 2013
Overdiagnosis in low-dose computed tomography screening for lung cancerEdward F Patz, Paul Pinsky, Constantine Gatsonis, et al.
American Journal of Cancer Research|September 9, 2020
Genetic variants of <i>BIRC3</i> and <i>NRG1</i> in the NLRP3 inflammasome pathway are associated with non-small cell lung cancer survivalDongfang Tang, Hongliang Liu, Yuchen Zhao, et al.
International Journal of Cancer|September 28, 2018
Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survivalDanwen Qian, Hongliang Liu, Xiaomeng Wang, et al.
Translational Lung Cancer Research|July 18, 2020
Novel genetic variants in genes of the Fc gamma receptor-mediated phagocytosis pathway predict non-small cell lung cancer survivalDanwen Qian, Hongliang Liu, Lingling Zhao, et al.
Translational Lung Cancer Research|June 13, 2022
Single nucleotide polymorphisms in <i>FOXP1</i> and <i>RORA</i> of the lymphocyte activation-related pathway affect survival of lung cancer patientsHailei Du, Rui Mu, Lihua Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancerBrandon A Howard, Zhong Zheng, Michael J Campa, et al.
Cancer|June 30, 2011
Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303)Andrew S Roberts, Michael J Campa, Elizabeth B Gottlin, et al.
Frontiers in Oncology|October 4, 2021
Genetic Variants of <i>CLPP</i> and <i>M1AP</i> Are Associated With Risk of Non-Small Cell Lung CancerXianghan Li, Yiran Zou, Teng Li, et al.
Cancer|October 23, 2025
A Phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non-small cell lung cancerHirva Mamdani, Ryan D Gentzler, Lin Gu, et al.
Molecular Carcinogenesis|November 13, 2019
Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancerDongfang Tang, Yu Chen Zhao, Danwen Qian, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
JAMA Internal Medicine|December 11, 2013
Overdiagnosis in low-dose computed tomography screening for lung cancerEdward F Patz, Paul Pinsky, Constantine Gatsonis, et al.
American Journal of Cancer Research|September 9, 2020
Genetic variants of <i>BIRC3</i> and <i>NRG1</i> in the NLRP3 inflammasome pathway are associated with non-small cell lung cancer survivalDongfang Tang, Hongliang Liu, Yuchen Zhao, et al.
International Journal of Cancer|September 28, 2018
Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survivalDanwen Qian, Hongliang Liu, Xiaomeng Wang, et al.
Translational Lung Cancer Research|July 18, 2020
Novel genetic variants in genes of the Fc gamma receptor-mediated phagocytosis pathway predict non-small cell lung cancer survivalDanwen Qian, Hongliang Liu, Lingling Zhao, et al.
Translational Lung Cancer Research|June 13, 2022
Single nucleotide polymorphisms in <i>FOXP1</i> and <i>RORA</i> of the lymphocyte activation-related pathway affect survival of lung cancer patientsHailei Du, Rui Mu, Lihua Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancerBrandon A Howard, Zhong Zheng, Michael J Campa, et al.
Cancer|June 30, 2011
Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303)Andrew S Roberts, Michael J Campa, Elizabeth B Gottlin, et al.
Frontiers in Oncology|October 4, 2021
Genetic Variants of <i>CLPP</i> and <i>M1AP</i> Are Associated With Risk of Non-Small Cell Lung CancerXianghan Li, Yiran Zou, Teng Li, et al.
Cancer|October 23, 2025
A Phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non-small cell lung cancerHirva Mamdani, Ryan D Gentzler, Lin Gu, et al.
Molecular Carcinogenesis|November 13, 2019
Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancerDongfang Tang, Yu Chen Zhao, Danwen Qian, et al.
Pageof 11